%PDF-1.4
%
77 0 obj
<>
endobj
71 0 obj
<>stream
Arbortext Advanced Print Publisher 9.1.406/W Unicode
2020-04-20T08:04:11-07:00
2014-12-03T16:56:59+05:30
2020-04-20T08:04:11-07:00
application/pdf
CCR-14-0409 6284..6294
pinnacle
Acrobat Distiller 10.1.10 (Windows)
uuid:7f51dd14-1dd2-11b2-0a00-6508271dd700
uuid:7f51dd18-1dd2-11b2-0a00-b00000000000
endstream
endobj
75 0 obj
<>
endobj
65 0 obj
<>
endobj
67 0 obj
<>
endobj
68 0 obj
<>
endobj
69 0 obj
<>
endobj
48 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[28.224 28.224 613.241 811.197]/Type/Page>>
endobj
127 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
132 0 obj
[138 0 R 139 0 R 140 0 R 141 0 R 142 0 R 143 0 R 144 0 R]
endobj
133 0 obj
<>stream
q
539.3594055 0 0 83.3014526 50.8202972 707.6985474 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 105.56985 591.99982 Tm
(2014;20:6284-6294. Published OnlineFirst October 2, 2014.)Tj
/T1_1 1 Tf
-7.55699 0 Td
(Clin Cancer Res\240)Tj
/T1_0 1 Tf
0 1 TD
(\240 )Tj
0 1.00001 TD
(L. Rhoda Molife, Emma Jane Dean, Montserrat Blanco-Codesido, et al. )Tj
/T1_2 1 Tf
0 1 TD
(\240 )Tj
/T1_3 1 Tf
18 0 0 18 30 631.99994 Tm
(Solid Tumors)Tj
T*
(Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced )Tj
T*
(A Phase I, Dose-Escalation Study of the Multitargeted Receptor)Tj
ET
30 537 581 35 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 544.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 536.99994 Tm
(\240 )Tj
/T1_0 1 Tf
16.73097 1 Td
( )Tj
0 0 1 rg
-15.11897 0 Td
(10.1158/1078-0432.CCR-14-0409)Tj
0 g
-1.612 0 Td
(doi:)Tj
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 516.99997 Tm
(\240 )Tj
0 1 TD
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 496.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
30 427 581 70 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 464.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-6.00198 1 Td
(Cited articles)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 456.99994 Tm
(\240 )Tj
/T1_0 1 Tf
30.40193 1 Td
( )Tj
0 0 1 rg
-30.40193 0 Td
(http://clincancerres.aacrjournals.org/content/20/24/6284.full#ref-list-1\
)Tj
0 g
0 1.00001 TD
(This article cites 44 articles, 14 of which you can access for free at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 434.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-6.33498 1 Td
(Citing articles)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 426.99994 Tm
(\240 )Tj
/T1_0 1 Tf
31.79193 1 Td
( )Tj
0 0 1 rg
-31.79193 0 Td
(http://clincancerres.aacrjournals.org/content/20/24/6284.full#related-ur\
ls)Tj
0 g
T*
(This article has been cited by 3 HighWire-hosted articles. Access the ar\
ticles at:)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 406.99997 Tm
(\240 )Tj
0 1 TD
(\240 )Tj
ET
30 292 581 115 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 374.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 295.49966 387 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44997 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 120.94202 341.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 344.99994 Tm
(\240 )Tj
6.85098 1 Td
(.)Tj
0 0 1 rg
-6.85098 0 Td
(pubs@aacr.org)Tj
0 g
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac\
t the AACR Publications Department at)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 319.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 291.99988 Tm
(\240 )Tj
0 1 TD
(Rightslink site. )Tj
0 1.00001 TD
(Click on "Request Permissions" which will take you to the Copyright Clea\
rance Center's \(CCC\))Tj
24.67896 1 Td
(.)Tj
0 0 1 rg
-24.67896 0 Td
(http://clincancerres.aacrjournals.org/content/20/24/6284)Tj
0 g
0 1 TD
(To request permission to re-use all or part of this article, use this li\
nk)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 277.65439 11 Tm
(on April 20, 2020. \251 2014 American Association for Cancer Research. )Tj
0 0 1 rg
-13.61496 0 Td
(clincancerres.aacrjournals.org )Tj
0 g
-8.11398 0 Td
(Downloaded from )Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 161.17572 826 Tm
(Published OnlineFirst October 2, 2014; DOI: 10.1158/1078-0432.CCR-14-040\
9 )Tj
ET
endstream
endobj
137 0 obj
<>/Filter/FlateDecode/Height 238/Length 73913/Name/X/Subtype/Image/Type/XObject/Width 1541>>stream
HϏn`'G6R0"#AKH"9\C| \?9-5= w#b"`ͼJ13;uKUoOu{^E +CD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd i꺖lƽeYڽ=
!Y2u]QEIeUQ:h\yq]&;qjm#qb^նmUUI-Vmi݃s}
էIiԮ{[R&LڝX;
;A;lDzog^ ilf $L2쪇͓ؿy$N&oar@1i|X$ݾwN9߄ͷ11&ldD ǩ}ƏVovT:np9i_ABM2$)4G&ʲL^UMupzXz~k˶
U\:p+aw!s+sa,ڙvm۪M5fIYO|IuUl1-&(|>Y&J%n0n/2%Ǻlnag^84|sb4 />]TI~~km۪lh4wY#nI:7eY~-İV?ߴML66C-睔Mj\